- Home
- WLYB vs AZTA Comparison
WLYB vs AZTA Comparison
Compare WLYB & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLYB
- AZTA
- Stock Information
- Founded
- WLYB 1807
- AZTA 1978
- Country
- WLYB United States
- AZTA United States
- Employees
- WLYB N/A
- AZTA N/A
- Industry
- WLYB Books
- AZTA Industrial Machinery/Components
- Sector
- WLYB Consumer Discretionary
- AZTA Technology
- Exchange
- WLYB Nasdaq
- AZTA Nasdaq
- Market Cap
- WLYB 2.7B
- AZTA 2.2B
- IPO Year
- WLYB N/A
- AZTA 1995
- Fundamental
- Price
- WLYB $51.93
- AZTA $41.51
- Analyst Decision
- WLYB
- AZTA Buy
- Analyst Count
- WLYB 0
- AZTA 5
- Target Price
- WLYB N/A
- AZTA $63.60
- AVG Volume (30 Days)
- WLYB 193.0
- AZTA 533.4K
- Earning Date
- WLYB 12-04-2024
- AZTA 11-12-2024
- Dividend Yield
- WLYB 2.68%
- AZTA N/A
- EPS Growth
- WLYB N/A
- AZTA N/A
- EPS
- WLYB N/A
- AZTA N/A
- Revenue
- WLYB $1,825,783,000.00
- AZTA $656,323,000.00
- Revenue This Year
- WLYB N/A
- AZTA $8.47
- Revenue Next Year
- WLYB $1.12
- AZTA $6.72
- P/E Ratio
- WLYB N/A
- AZTA N/A
- Revenue Growth
- WLYB N/A
- AZTA N/A
- 52 Week Low
- WLYB $28.35
- AZTA $40.24
- 52 Week High
- WLYB $52.58
- AZTA $69.16
- Technical
- Relative Strength Index (RSI)
- WLYB 69.63
- AZTA 38.58
- Support Level
- WLYB $49.30
- AZTA $44.72
- Resistance Level
- WLYB $52.29
- AZTA $50.81
- Average True Range (ATR)
- WLYB 0.08
- AZTA 2.24
- MACD
- WLYB 0.16
- AZTA 0.04
- Stochastic Oscillator
- WLYB 88.77
- AZTA 5.78
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.